Table 1 Established function of myricetin in different cancer cell lines
From: Myricetin: targeting signaling networks in cancer and its implication in chemotherapy
Cell lines/in vitro | Tumor type | Effect of Myricetin | Reference |
|---|---|---|---|
DU145 PC3 | Prostate Cancer | ↓ metastasis, ↓epithelial-mesenchymal transition ↓invasiveness, ↑apoptosis | [118] |
HCT-15 HT-29 | Colon cancer | ↑apoptosis ↓inhibits proliferation in a dose-dependent manner | |
HepG2 A549 H1299 | Hepatocellular Carcinoma | ↑growth arrest, ↑ autophagy ↑growth arrest ↓proliferation | |
HGC-27 SGC7901 | Gastric Cancer | ↓ proliferation ↓growth ↑apoptosis in a dose-dependent manner | [20] |
KYSE30 EC9706 | Esophageal Carcinoma | ↓proliferation, ↑apoptosis, ↓migration ↓invasion of tumor cells in a dose-dependent manner | [119] |
MCF-7 MDA-Mb-231 | Breast Cancer Cells | ↑ apoptosis, ↓metastasis, ↓migration, ↓invasion | |
OVCAR-3 A2780/CP70 SKOV3 | Ovarian Cancer | ↑ apoptosis ↓cells migration ↓angiogenesis | [125] |
Panc1 S2-013 PaCa-2 | Pancreatic Cancer | ↑apoptosis | [75] |
T24 | Bladder Cancer | ↑ growth arrest at M-phase, ↑apoptosis, ↓proliferation, ↓cell migration | [105] |